Friday, May 13, 2016

IDEXX Laboratories Earnings Analysis

IDEXX Laboratories (NASDAQ:IDXX) and its management cheered the market by doing something few companies have done in the current earnings season: raise full-year guidance, generate double-digit organic revenue growth, and talk of more favorable end markets. In a moderately growing economy, the stock stands out for its growth prospects. Let's look at the highlights from the veterinary health specialist's recent first quarter to see what's going on.

READ THE FULL EQUITY RESEARCH REPORT LINKED